HuMax-CD4 (Zanolimumab), a fully human monoclonal antibody: Early results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphoma of non-cutaneous type

d'Amore, Francesco and Relander, T. and Hagberg, H. and Osterborg, A. and Hansen, M. and Moeller, L. and Johnson, P. and Radford, J. and Hancock, B. and Gramatzki, M. and Krause, S. and Dreyling, M. and Schmitz, N. and Lisby, S. and Baadsgaard, O. (2005) HuMax-CD4 (Zanolimumab), a fully human monoclonal antibody: Early results of an ongoing clinical trial in CD4(+) peripheral T-cell lymphoma of non-cutaneous type. In: 47th Annual Meeting of the American Society of Hematology, December 10-13, 2005, Atlanta, GA.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 23 Jun 2022 05:53
Last Modified: 23 Jun 2022 05:53
URI: https://pred.uni-regensburg.de/id/eprint/35428

Actions (login required)

View Item View Item